Antibody capable of specifically recognizing transferrin receptor
US9593165B2 · kind B2 · utility
3Cited by
3References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 8, 2013 |
| Grant date | Mar 14, 2017 |
| Priority date | — |
| Expiry date | Nov 8, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an antibody, in which the heavy chain first complementarity determining region (VH CDR1), the heavy chain second complementarity determining region (VH CDR2), and the heavy chain third complementarity determining region (VH CDR3) are shown in SEQ ID NOs: 1, 2, and 7, respectively, and the light chain first complementarity determining region (VL CDR1), the light chain second complementarity determining region (VL CDR2), and the light chain third complementarity determining region (VL CDR3) are shown in SEQ ID NOs: 4, 5, and 6, respectively.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.